首页> 外文OA文献 >Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO‐04 randomized phase 3 rectal cancer trial

【2h】

Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO‐04 randomized phase 3 rectal cancer trial

机译：白细胞增生和中性粒细胞作为独立预后免疫生物标志物在CaO / Aro / AiO-04随机化相3直肠癌试验中进行临床结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Markus Diefenhardt; Ralf‐Dieter Hofheinz; Daniel Martin; Tim Beißbarth; Dirk Arnold; Arndt Hartmann; Jens Grün; Robert Grützmann; Torsten Liersch; Philipp Ströbel; Gerhard G. Grabenbauer; Michael Rieger; Rainer Fietkau; Ullrich Graeven; Jürgen Weitz; Gunar Folprecht; Michael Ghadimi; Franz Rödel; Claus Rödel; Emmanouil Fokas;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO‐04 randomized phase 3 rectal cancer trial [J] . Diefenhardt Markus, Hofheinz Ralf‐Dieter, Martin Daniel, International Journal of Cancer =: Journal International du Cancer . 2019,第8期

机译：白细胞增多症和中性粒细胞作为独立预后免疫生物标志物在CaO / Aro / AiO-04随机相3直肠癌试验中进行临床结果
2. Leukocytosis and Neutrophilia as independent prognostic Biomarkers for clinical Outcome in the randomized Phase III CAO/ARO/AIO-04 Rectal Cancer Study [J] . Diefenhardt M., Hofheinz R-D, Martin D., Strahlentherapie und Onkologie . 2019,第Suppla1期

机译：白细胞增多症和中性粒细胞作为独立预后生物标志物，用于随机阶段III / ARO / AIO-04直肠癌研究中的临床结果
3. Can local excision be safely recommended in patients with ypT0-2 rectal cancer after chemoradiotherapy? Clinicopathological results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 randomized phase 3 trials [J] . von den Gruen Mueller J., Hartmann A., Fietkau R., Strahlentherapie und Onkologie . 2018,第Suppla1期

机译：在化学机制后，在YPT0-2直肠癌直肠癌患者中，可以安全地建议当地切除术语吗？ CaO / Aro / AiO-94和CaO / Aro / AiO-04随机阶段3试验的临床病理结果
4. Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO ARO and CAO) [O] . Thomas B Brunner, Gerhard G Grabenbauer, Thomas Meyer, 2007

机译：初次切除与新辅助化学放疗然后切除局部可切除或潜在可切除的胰腺癌而无远处转移。跨学科工作组胃肠道肿瘤（AIOARO和CAO）的多中心前瞻性随机II期研究
5. O-0028PREOPERATIVE CHEMORADIOTHERAPY AND POSTOPERATIVE CHEMOTHERAPY WITH 5-FLUOROURACIL AND OXALIPLATIN VERSUS 5-FLUOROURACIL ALONE IN LOCALLY ADVANCED RECTAL CANCER: RESULTS OF THE GERMAN CAO/ARO/AIO-04 RANDOMIZED PHASE III TRIAL [O] . Graeven, U., Liersch, T., Fietkau, R., 2017

机译：局部晚期直肠癌的O-0028术前化疗和5-氟尿嘧啶和草酰戊对5氟尿嘧啶的术后化疗：德国CAO / ARO / AIO-04随机III期临床试验的结果

Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO‐04 randomized phase 3 rectal cancer trial

著录项

引文网络

相似文献

相关主题

期刊订阅